HC Wainwright & Co. Reiterates Buy on Fractyl Health, Maintains $8 Price Target

Benzinga · 3d ago
HC Wainwright & Co. analyst Joseph Pantginis reiterates Fractyl Health (NASDAQ:GUTS) with a Buy and maintains $8 price target.